George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Regulatory News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 22.00
Ask: 24.00
Change: -0.50 (-2.13%)
Spread: 2.00 (9.091%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 23.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Mar 2024 11:18

RNS Number : 3482I
Oncimmune Holdings PLC
26 March 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYQ94H38

Issuer Name

ONCIMMUNE HOLDINGS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

22-Mar-2024

6. Date on which Issuer notified

25-Mar-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.485800

3.528400

6.014200

4459057

Position of previous notification (if applicable)

2.485800

3.427200

5.913000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYQ94H38

1843032

2.485800

Sub Total 8.A

1843032

2.485800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

2616025

3.528400

Sub Total 8.B1

2616025

3.528400%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

25-Mar-2024

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLJFMBTMTBTBRI
Date   Source Headline
26th Apr 20247:00 amRNSAppointment of Nominated Adviser and Joint Broker
25th Apr 202410:44 amRNSHolding(s) in Company
2nd Apr 202411:34 amRNSResult of General Meeting
2nd Apr 20248:00 amRNSTotal Voting Rights
26th Mar 202411:18 amRNSHolding(s) in Company
13th Mar 20245:32 pmRNSBlock Listing Return
6th Mar 20243:02 pmRNSPosting of Notice of General Meeting
1st Mar 20241:00 pmRNSInvestor Presentation via Investor Meet Company
29th Feb 202411:19 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFinal Results
26th Feb 202411:30 amRNSResult of AGM
2nd Feb 20247:00 amRNSNotice of AGM
11th Dec 20233:12 pmRNSDirector/PDMR Shareholding
8th Dec 20232:31 pmRNSGrant of Options and PDMR Dealing
30th Nov 20237:00 amRNSProgress against Strategy
10th Nov 202310:14 amRNSHolding(s) in Company
7th Nov 20234:11 pmRNSGrant of Options and PDMR Dealing
19th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
12th Oct 20237:00 amRNSUpdate on Strategy & Changes to the Board
1st Aug 20237:00 amRNSBoard Changes
14th Jul 20232:00 pmRNSCorrected unaudited interim results to 31 May 2022
12th Jul 20237:00 amRNSAppointment of new leadership team & board changes
26th Jun 202311:10 amRNSChange of registered office
23rd Jun 20237:00 amRNSTransition of Executive Leadership
15th Jun 20235:16 pmRNSCorrection to interim results
13th Jun 20237:45 amRNSHolding(s) in Company
5th Jun 20234:02 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSInterim Results
22nd May 20237:00 amRNSSale of Oncimmune Limited to Freenome
3rd Apr 20234:38 pmRNSHolding(s) in Company
27th Mar 202311:07 amRNSResult of GM
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of GM
27th Feb 20232:36 pmRNSResult of AGM
27th Feb 20237:00 amRNSFinal Results
23rd Feb 20237:00 amRNSAppointment of Joint Broker
17th Feb 20237:00 amRNSSiemens Healthineers Collaboration
3rd Feb 202311:50 amRNSNotice of AGM
31st Jan 20237:00 amRNSNotice of Results
13th Jan 20237:00 amRNSAppointment of Non-Executive Director
20th Dec 20227:00 amRNSImmunoINSIGHTS Trading Update
19th Dec 20221:35 pmRNSDirector/PDMR Shareholding
14th Dec 20222:00 pmRNSResult of Capital Raising
9th Dec 20221:30 pmRNSExtension of Capital Raising
7th Dec 20222:00 pmRNSProposed Placing and Subscription
4th Nov 20224:16 pmRNSGrant of Options and PDMR Dealing
21st Sep 20222:16 pmRNSPDMR Dealing
21st Sep 20227:00 amRNSUnaudited results for the 12 months to 31 May 2022
30th Aug 20223:53 pmRNSRevised Notice of Results
15th Aug 20222:06 pmRNSHolding(s) in Company
8th Aug 202211:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.